FDA-Drug2012-12-26Class II
Nalbuphine HCl Injection, 20 mg/mL, 10 mL Multiple-dose Fliptop Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1467-01
Hospira, Inc.
Hazard
Lack of Assurance of Sterility: Complains of a loose crimp applied to the fliptop vial; and a missing stopper and flip cap were received and therefore sterility cannot be assured.
Sold states
Nationwide and Puerto Rico.
Affected count
145,400 vials
Manufactured in
600 N Field Dr Bldg J45, Lake Forest, IL, United States
Products
Nalbuphine HCl Injection, 20 mg/mL, 10 mL Multiple-dose Fliptop Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1467-01
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-096-2013Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief